Compositions comprising nicotinic agonists and methods of using same
AssigneeNeuroDerm, Ltd.
InventorEliahu Heldman
Life of this patent
Estimating the term…
Abstract
The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in particular, to combination therapies that include a nicotinic agonist (for example, nicotine) and a nicotinic acetylcholine receptor desensitization inhibitor (for example, opipramol).
Claims13
A pharmaceutical composition, comprising:
- a) nicotine or pharmaceutically acceptable salts or N-oxides thereof, and b) opipramol or pharmaceutically acceptable salts, or esters, thereof.
A transdermal patch for administration of a co-therapy to a patient, wherein said patch comprises a) nicotine, b) opipramol or pharmaceutically acceptable salts, or esters, thereof, and c) a pharmaceutically acceptable carrier suitable for transdermal or topical administration to a patient.
Dependencies are inferred from the claim text.